Baclofen for persistent heartburn or regurgitation
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether the drug baclofen can help patients who still have acid reflux symptoms (heartburn or regurgitation) despite taking standard treatments like PPIs for 8 weeks. If you've tried PPIs and still have symptoms, this may be an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have ongoing heartburn or regurgitation even after taking standard reflux medication (PPI) for at least 8 weeks.
- You do not have any concerning symptoms like trouble swallowing, unexplained weight loss, bleeding, vomiting, or anemia.
- Your GERD symptom score (GERD Q) must be 8 or more.
- You do not have an active stomach or duodenal ulcer or other serious esophagus conditions.
- You are not pregnant or breastfeeding, and you do not have kidney problems or uncontrolled thyroid/diabetes issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, JP-1366, for people with non-erosive GERD (heartburn and acid reflux without visible damage to the esophagus). The goal is to see if it helps control symptoms better than a placebo.
This study tests a new topical treatment for people with chronic heartburn and acid regurgitation who don't have erosions (damage) in their esophagus. The treatment is applied directly to the affected area and may help relieve symptoms without taking daily pills.
This trial tests a combination of two medicines, fosamprenavir and sodium alginate, to see if they work better than standard treatment for people with ongoing GERD symptoms. It is for adults who still have heartburn despite taking daily PPI medication.
This trial tests a new way to treat GERD (chronic acid reflux) using a tiny camera and a device that delivers a gentle heat treatment (argon plasma coagulation) to the area where the stomach meets the esophagus. It's compared to a 'sham' procedure (you won't know which you get) to see if it stops acid from backing up better than medicine alone.
This study tests a new procedure called anti-reflux mucosal ablation to see if it helps people with long-lasting heartburn and acid reflux. It might be an option if medications haven't fully controlled your symptoms.
This trial compares the Stretta procedure to standard “conservative” treatment for people with ongoing GERD symptoms despite taking acid pills (PPIs). It aims to see whether Stretta can better control reflux and possibly help people stop or reduce PPIs safely.
Hear when a new GERD - PPI Non-responders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.